HUTCHMED Research Development from 2010 to 2026

HCM Stock  USD 15.22  0.02  0.13%   
HUTCHMED DRC Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to grow to about 257.6 M this year. During the period from 2010 to 2026, HUTCHMED DRC Research Development quarterly data regression pattern had sample variance of 11136.7 T and median of  78,821,000. View All Fundamentals
 
Research Development  
First Reported
2012-09-30
Previous Quarter
36 M
Current Value
36 M
Quarterly Volatility
37.1 M
 
Yuan Drop
 
Covid
 
Interest Hikes
Check HUTCHMED DRC financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among HUTCHMED DRC's main balance sheet or income statement drivers, such as Depreciation And Amortization of 14.9 M, Interest Expense of 3.5 M or Selling And Marketing Expenses of 32.3 M, as well as many indicators such as Price To Sales Ratio of 4.33, Dividend Yield of 0.0024 or PTB Ratio of 3.59. HUTCHMED financial statements analysis is a perfect complement when working with HUTCHMED DRC Valuation or Volatility modules.
  
Build AI portfolio with HUTCHMED Stock
Check out the analysis of HUTCHMED DRC Correlation against competitors.
To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.

Latest HUTCHMED DRC's Research Development Growth Pattern

Below is the plot of the Research Development of HUTCHMED DRC over the last few years. It is HUTCHMED DRC's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in HUTCHMED DRC's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

HUTCHMED Research Development Regression Statistics

Arithmetic Mean118,441,966
Geometric Mean60,637,648
Coefficient Of Variation89.10
Mean Deviation92,212,963
Median78,821,000
Standard Deviation105,530,748
Sample Variance11136.7T
Range301M
R-Value0.93
Mean Square Error1679.1T
R-Squared0.86
Slope19,364,958
Total Sum of Squares178187.8T

HUTCHMED Research Development History

2026257.6 M
2025245.4 M
2024213.4 M
2023303.1 M
2022267.6 M
2021207.4 M
2020111.2 M

About HUTCHMED DRC Financial Statements

HUTCHMED DRC investors utilize fundamental indicators, such as Research Development, to predict how HUTCHMED Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development245.4 M257.6 M

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Prophet is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Prophet
When determining whether HUTCHMED DRC is a strong investment it is important to analyze HUTCHMED DRC's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact HUTCHMED DRC's future performance. For an informed investment choice regarding HUTCHMED Stock, refer to the following important reports:
Check out the analysis of HUTCHMED DRC Correlation against competitors.
To learn how to invest in HUTCHMED Stock, please use our How to Invest in HUTCHMED DRC guide.
You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Will Pharmaceuticals sector continue expanding? Could HUTCHMED diversify its offerings? Factors like these will boost the valuation of HUTCHMED DRC. Market participants price HUTCHMED higher when confident in its future expansion prospects. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every HUTCHMED DRC data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth
16.333
Earnings Share
2.65
Revenue Per Share
3.52
Quarterly Revenue Growth
(0.09)
Return On Assets
(0.01)
Understanding HUTCHMED DRC requires distinguishing between market price and book value, where the latter reflects HUTCHMED's accounting equity. The concept of intrinsic value—what HUTCHMED DRC's is actually worth based on fundamentals—guides informed investors toward better entry and exit points. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Market sentiment, economic cycles, and investor behavior can push HUTCHMED DRC's price substantially above or below its fundamental value.
Please note, there is a significant difference between HUTCHMED DRC's value and its price as these two are different measures arrived at by different means. Investors typically determine if HUTCHMED DRC is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, HUTCHMED DRC's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.